High-Quality Data and Growing Capacity Make Sub-Saharan Africa a Research Destination

With experienced researchers and sites, investment in research infrastructure by local and overseas organizations as well as engaged stakeholders, Africa should be a research destination for pharma, biotech, government and non-governmental organizations alike.

Continue ReadingHigh-Quality Data and Growing Capacity Make Sub-Saharan Africa a Research Destination

Increasing Clinical Research In Africa Presents An Opportunity To Address Global Health Challenges

Although the diversity of Africa is often cited, the full extent is still not well understood. As we learn more, the true potential of the continent for clinical research to address ongoing public health issues becomes apparent.

Continue ReadingIncreasing Clinical Research In Africa Presents An Opportunity To Address Global Health Challenges

Acknowledging the Dynamic Epidemiology of Infectious Diseases During Clinical Trial Planning

The dynamic nature of infectious disease epidemiology requires diligent surveillance to ensure clinical trials of vaccines and treatments can successfully recruit and account for changing seroprevalence and new variants.

Continue ReadingAcknowledging the Dynamic Epidemiology of Infectious Diseases During Clinical Trial Planning

Q&A From Our Webinar — Africa’s Potential for Clinical Research: Population Diversity, Expanding Therapeutic Area Expertise and Long-Standing Stakeholder Engagement

In our recent webinar, our panel of esteemed speakers broke stereotypes about Africa, discussed research-related trends and highlighted how clinical trials could benefit from the continent’s strengths.

Continue ReadingQ&A From Our Webinar — Africa’s Potential for Clinical Research: Population Diversity, Expanding Therapeutic Area Expertise and Long-Standing Stakeholder Engagement

Meet Daniel Joffe, Senior Clinical Project Manager

Meet Daniel Joffe, Senior Clinical Project Manager at FHI Clinical. “It can be a tough job­ — but it’s the most amazing feeling when things come together, for example, when a site or study is initiated. You look back and see what we accomplished as a team. That's the reward — when you know that all the hard work paid off. That's what keeps me motivated.”

Continue ReadingMeet Daniel Joffe, Senior Clinical Project Manager

New Horizons for TB Vaccine Research Involve Early Awareness, Coordinated Efforts and Equitable Access: Thoughts from the 6th Annual Global Forum on TB Vaccines

Several FHI Clinical team members attended the 6th Annual Global Forum on TB Vaccines. Based on their conversations and session attendance, they provide their thoughts on the future of tuberculosis prevention and vaccine development.

Continue ReadingNew Horizons for TB Vaccine Research Involve Early Awareness, Coordinated Efforts and Equitable Access: Thoughts from the 6th Annual Global Forum on TB Vaccines

Personal Choice in Research: Respecting Reasons for Participation and Nonparticipation

As researchers, we rely on the willingness of people to participate in our studies, and participant recruitment and retention continue to be one of the biggest challenges. There are numerous reasons for this, some that we can address and others that we might just have to accept.

Continue ReadingPersonal Choice in Research: Respecting Reasons for Participation and Nonparticipation